Sandostatin LAR depot 10 MG KTS
Ended Awarded Last action
- Contract number
- SPE2DR26FQS5S
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,612
Award facts
- Contract value 100% obligated
- $36,612.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Sandostatin LAR Depot 10 mg kits valued at $36,612.17 under a firm fixed-price contract type. The award, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery order is a child contract action under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and extending through December 2026.
Sandostatin LAR Depot (octreotide acetate) is a long-acting somatostatin analog used primarily for the treatment of acromegaly and other neuroendocrine disorders. This procurement supports the DLA's Medical Supply Chain mission to provide critical pharmaceutical commodities to military healthcare systems, the Defense Health Agency, and other federal healthcare entities. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its established capability as a major pharmaceutical distributor serving defense medical procurement needs, with consistent delivery of brand-name medications, specialty treatments, and medical supplies across multiple therapeutic domains through competitively awarded contracts.
Quick answers
Who was awarded contract SPE2DR26FQS5S?
SPE2DR26FQS5S was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FQS5S worth?
The government has obligated $36,612 on SPE2DR26FQS5S.
Is contract SPE2DR26FQS5S an order under another contract?
Yes. SPE2DR26FQS5S is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQS5S competed?
The extent of competition for SPE2DR26FQS5S was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award